1AD1.F ADDLIFE AB B
- Market cap
- EUR 2.00B
- P/E
- 34.3x
- P/B
- 3.75x
- ROE
- 8.6%
- Dividend yield
- 0.83%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 1AD1.F undervalued?
Graham number1AD1.F trades 138.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ADDLIFE AB B fundamental analysis
No fundamental analysis for ADDLIFE AB B yet.
ADDLIFE AB B stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ADDLIFE AB B
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytic…
Full company profileADDLIFE AB B financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ADDLIFE AB B annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 9.08B | 9.69B | 10.3B | 10.4B | 10.6B |
| Gross Profit | 3.43B | 3.60B | 3.86B | 3.98B | 4.13B |
| Operating Income | 712M | 437M | 716M | 829M | 915M |
| EBITDA | 1.44B | 1.53B | 1.52B | 1.78B | 915M |
| Net Income | 480M | 190M | 252M | 560M | 512M |
| EPS | 3.94 | 1.56 | 2.07 | 4.60 | 4.20 |
| Balance Sheet | |||||
| Total Assets | 13.1B | 12.7B | 13.1B | 12.7B | 13.6B |
| Total Liabilities | 8.09B | 7.79B | 7.75B | 7.26B | 7.67B |
| Shareholders' Equity | 4.97B | 4.96B | 5.31B | 5.44B | 5.95B |
| Cash & Short-term Investments | 376M | 272M | 331M | 813M | 477M |
| Cash Flow | |||||
| Operating Cash Flow | 909M | 773M | 1.10B | 1.39B | 673M |
| Capital Expenditure | 282M | 308M | 297M | 284M | 0.00 |
| Free Cash Flow | 627M | 465M | 1.10B | 1.11B | 673M |
| Ratios | |||||
| ROE | 9.7% | 3.8% | 4.7% | 10.3% | 8.6% |
| ROA | 3.7% | 1.5% | 1.9% | 4.4% | 3.8% |
| Net Profit Margin | 5.3% | 2.0% | 2.4% | 5.4% | 4.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ADDLIFE AB B dividends
- Dividend yield
- 0.83%
- Forward dividend
- 0.14 EUR
- Payout ratio
- 16.3%
- Ex-dividend date
- May 7, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | SEK 91.0M | 0.75 | 16.3% |
| 2024 | SEK 61.0M | 0.50 | 24.2% |
| 2023 | SEK 146M | 1.20 | 76.8% |
| 2022 | SEK 243M | 1.99 | 50.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 4:1 on May 27, 2020.
Who owns ADDLIFE AB B
- Insiders 5.31%
- Institutions 79.33%
- Public & others 15.37%
- Shares outstanding 117M
- Free float 113M
ADDLIFE AB B company profile
- Company name
- ADDLIFE AB B
- Ticker
- 1AD1.F
- ISIN
- SE0014401378
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2,428
- Fiscal year end
- December
- Address
- Brunkebergstorg 5, Stockholm, Sweden, 103 62
- Phone
- 46 8 42 00 38 30
- Website
- add.life
About ADDLIFE AB B
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical services; and in the areas of microbiology, clinical chemistry, coagulation, molecular biology, research, immunology, point-of-care testing, veterinary diagnostics, as well as in the food industry. This segment also provides training programs for its customers. The Medtech segment provides medical device products for surgery, orthopaedics, critical care, endoscopy, wound care, healthcare IT, ophthalmology, home adaptation, and technical aids, as well as surgical procedures, welfare technology, and assistive devices for the elderly and disabled. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, Poland, Austria, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
ADDLIFE AB B management
6- Mr. Fredrik DalborgPresident & CEO · born 1972
- Ms. Christina RubenhagChief Financial Officer · born 1970
- Julie O'LearyInvestor Relations Manager
- Timmy RosendalHead of Sustainability
- Ms. Jamilah WassGroup Financial Controller
- Johanna PrimGroup Financial Controller